Marcelino Bermudez Lopez
Grau: Doctor/a
973702482
mbermudez(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/C-3787-2011
Publicacions
-
Sanchez, E; Sapiña-Beltrán E; Gavalda, R; Barbe, F; Torres, G; Sauret, A; Dalmases, M; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Bermudez-Lopez, M; Fernandez, E; Purroy, F; Castro-Boque, E; Farràs-Sallés C; Pamplona, R; Mauricio, D; Hernandez, C; Simo, R; Lecube, A
Prediabetes Is Associated with Increased Prevalence of Sleep-Disordered Breathing.
Journal of Clinical Medicine 11 -. .
-
Núñez E; Fuster, V; Gomez-Serrano, M; Valdivielso, JM; Fernandez-Alvira, JM; Martinez-Lopez, D; Rodriguez, JM; Bonzon-Kulichenko, E; Calvo, E; Alfayate, A; Bermudez-Lopez, M; Escola-Gil, JC; Fernandez-Friera, L; Cerro-Pardo, I; Mendiguren, JM; Sanchez-Cabo, F; Sanz, J; Ordovas, JM; Blanco-Colio, LM; Garcia-Ruiz, JM; Ibáñez B; Lara-Pezzi, E; Fernandez-Ortiz, A; Martin-Ventura, JL; Vazquez, J
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis.
EBioMedicine 76 103874-103874. .
-
Teis A.; Castelblanco E.; Cediel G.; Amigó N.; Julve J.; Ribalta J.; Guardiola M.; Franch J.; Bermúdez-López M.; Codina P.; Lupón J.; Mauricio D.; Alonso N.; Bayés-Genís A.
1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls
REVISTA ESPANOLA DE CARDIOLOGIA 75 867-876. .
-
Purroy F; Sánchez E; Lecube A; Arqué G; Vicente-Pascual M; Mauri-Capdevila G; Torreguitart N; Hernández M; Barbé F; Fernández E; Pamplona R; Farràs C; Mauricio D; Bermúdez-López M
Prevalence and Predictors of Cerebral Microangiopathy Determined by Pulsatility Index in an Asymptomatic Population From the ILERVAS Project.
Frontiers in Neurology 12 785640-785640. .
-
Castelblanco E; Hernández M; Ortega E; Amigó N; Real J; Granado-Casas M; Miñambres I; Lopez C; Lecube A; Bermúdez-López M; Alonso N; Julve J; Mauricio D
Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control.
DIABETES RESEARCH AND CLINICAL PRACTICE 182 109145-109145. .
-
Bermudez-Lopez M; Perpiñan H; Amigo N; Castro E; Alonso N; Mauricio D; Fernandez E; Valdivielso JM
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.
CLINICAL KIDNEY JOURNAL 14 2591-2599. .
-
Bermúdez-López M; Martínez-Alonso M; Castro-Boqué E; Betriu À; Cambray S; Farràs C; Barbé F; Pamplona R; Lecube A; Mauricio D; Purroy F; Valdivielso JM; Fernández E; ILERVAS project collaborators
Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study.
REVISTA ESPANOLA DE CARDIOLOGIA 74 1042-1053. .
-
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Aging-US 13 22690-22709. .
-
Bozic, Milica; Diaz-Tocados, Juan M.; Bermudez-Lopez, Marcelino; Forne, Carles; Martinez, Cristina; Fernandez, Elvira; Valdivielso, Jose M.
Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 1-10. .
-
Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A
Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.
Nutrients 13 1-15. .
-
Sapiña-Beltrán E; Gracia-Lavedan E; Torres G; Gaeta AM; Paredes J; Mayoral A; Fernández E; Bermúdez-López M; Valdivielso JM; Farràs-Salles C; Pamplona R; Lecube A; de Batlle J; Barbé F; Dalmases M
Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild-Moderate Cardiovascular Risk.
ARCHIVOS DE BRONCONEUMOLOGIA 58 490-497. .
-
Bermúdez-López, Marcelino; Martínez-Alonso, Montse; Castro-Boqué, Eva; Betriu, Àngels; Cambray, Serafí; Farràs, Cristina; Barbé, Ferran; Pamplona, Reinald; Lecube, Albert; Mauricio, Dídac; Purroy, Francisco; Valdivielso, José Manuel; Fernández, Elvira
Localización y carga de ateromatosis subclínica en población con un riesgo cardiovascular bajo-moderado: estudio ILERVAS
REVISTA ESPANOLA DE CARDIOLOGIA 74 1043-1054. .
Projectes
- ANGEL: A machine learning algorithm to predict atherosclerotic cardiovascular disease.
- Impacto del Manejo de los Trastornos Respiratorios Durante el Sueño en el control de la hipertensión sistémica: Proyecto METASLEEP
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Projecte d'Investigació ILERVAS - 2022
- Ayudas Juan de la Cierva - Incorporación 2018
- Projecte d'investigació ILERVAS -2020 Diputació
- Caracterización de un perfil lipidomico y lipídico de riesgo aterogénico y de morbimortalidad cardiovascular en la enfermedad renal crónica (estadios 3 a 5) (estudio prospectivo NEFRONA)
- AJUT PER A LA CONTRACTACIÓ D'UN NOU INVESTIGADOR
